How to buy VBI Vaccines (VBIV) shares in Australia
Learn how to easily invest in VBI Vaccines shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
VBI Vaccines Inc is a biotechnology business with stocks listed in the US. VBI Vaccines shares (VBIV) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$2.86 – a decrease of 5.3% over the previous week. Here's how to invest if you're based in Australia.
How to buy shares in VBI Vaccines
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for VBI Vaccines. Find the share by name or ticker symbol: VBIV. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until VBI Vaccines reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$3.02, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of VBI Vaccines, depending on your broker.
- Check in on your investment. Congratulations, you own a part of VBI Vaccines. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
VBI Vaccines stock price (NASDAQ:VBIV)Use our graph to track the performance of VBIV stocks over time.
VBI Vaccines shares at a glance
|52-week range||US$2.44 - US$4.83|
|50-day moving average||US$3.0842|
|200-day moving average||US$3.2184|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$-0.264|
Where to buy VBI Vaccines stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy VBI Vaccines stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Considering buying VBI Vaccines shares?Before you consider VBI Vaccines, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.
Show me how
VBI Vaccines price performance over time
|1 week (2021-11-18)||-5.30%|
|1 month (2021-10-26)||-3.05%|
|3 months (2021-08-26)||-15.63%|
|6 months (2021-05-26)||-11.18%|
|1 year (2020-11-25)||5.15%|
|2 years (2019-11-25)||318.37%|
|3 years (2018-11-23)||63.43%|
|5 years (2016-11-25)||-5.30%|
Stocks similar to VBI Vaccines
VBI Vaccines financials
|Gross profit TTM||US$-8,107,000|
|Return on assets TTM||-18.1%|
|Return on equity TTM||-40.7%|
|Market capitalisation||US$766.8 million|
TTM: trailing 12 months
VBI Vaccines share dividends
We're not expecting VBI Vaccines to pay a dividend over the next 12 months.
Have VBI Vaccines's shares ever split?
VBI Vaccines's shares were split on a 1:40 basis on 1 May 2016. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your VBI Vaccines shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for VBI Vaccines shares which in turn could have impacted VBI Vaccines's share price.
VBI Vaccines share price volatility
Over the last 12 months, VBI Vaccines's shares have ranged in value from as little as US$2.44 up to US$4.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while VBI Vaccines's is 1.9268. This would suggest that VBI Vaccines's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
VBI Vaccines overview
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. The company primarily serves physicians and pharmacists through direct sales. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition For Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.
VBI Vaccines in the news
VBI Vaccines to Participate in Jefferies London Healthcare Conference
VBI Vaccines : to Participate in Jefferies London Healthcare Conference - Form 8-K
VBI VACCINES INC/BC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Frequently asked questions
More guides on Finder
Amazon Australia Black Friday 2021: All the best deals so far
Amazon's best Black Friday deals include 50% off video games, 40% on Samsung Galaxy smartphones, 70% off Kindle books.
Sony Alpha ZV-E10 review: Best camera for vlogging?
If you’re a content creator or vlogger, the Sony Alpha ZV-E10 could be the mirrorless, interchangeable lens camera you have been looking for.
Inflation: What is it and do you need to worry about it right now?
For the first time in a decade Australia has a rising inflation rate. We discuss what it means for households, wages and how investors should react to higher inflation.
Black Friday deal: 34% off PlayStation Plus 12-month membership
Amazon has knocked 34% off PlayStation Plus 12 Month Membership cards as part of its mid-year sale - save $27.95!
Black Friday fashion sales 2021: The best deals so far
2021's best early-bird Black Friday fashion deals include 60% off at JD Sports, 80% off at White Fox Boutique and 50% off at THE ICONIC
How I saved $16k by refinancing my home loan twice in 2 years
Bank CEOs must hate me because I save so much money on my mortgage. Here's how I do it.
Ethereum price crashes as major market meltdown continues to unfold
Ethereum continues to struggle as the currency’s weekly losses now stand at 13.3%.
Jetstar’s EPIC Return for Free sale is back with international flights
There are over 500,000 seats on sale and for the first time in 2 years, fly to 22 international destinations.
Ask an Expert